CN119137268B - 工程化核酸酶、组合物及其使用方法 - Google Patents

工程化核酸酶、组合物及其使用方法

Info

Publication number
CN119137268B
CN119137268B CN202380038039.XA CN202380038039A CN119137268B CN 119137268 B CN119137268 B CN 119137268B CN 202380038039 A CN202380038039 A CN 202380038039A CN 119137268 B CN119137268 B CN 119137268B
Authority
CN
China
Prior art keywords
amino acid
acid residues
nucleotides
seq
engineered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202380038039.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN119137268A (zh
Inventor
杨潇
亓磊
文森特·库蒂拉斯
加布里埃拉·阿尔瓦雷斯
塔比莎·蒂乔
丹尼尔·哈特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epicrispil Biotechnology Co
Original Assignee
Epicrispil Biotechnology Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epicrispil Biotechnology Co filed Critical Epicrispil Biotechnology Co
Publication of CN119137268A publication Critical patent/CN119137268A/zh
Application granted granted Critical
Publication of CN119137268B publication Critical patent/CN119137268B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C12N9/222—Clustered regularly interspaced short palindromic repeats [CRISPR]-associated [CAS] enzymes
    • C12N9/226—Class 2 CAS enzyme complex, e.g. single CAS protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN202380038039.XA 2022-03-01 2023-03-01 工程化核酸酶、组合物及其使用方法 Active CN119137268B (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202263315159P 2022-03-01 2022-03-01
US63/315,159 2022-03-01
US202263380178P 2022-10-19 2022-10-19
US63/380,178 2022-10-19
US202263385171P 2022-11-28 2022-11-28
US63/385,171 2022-11-28
PCT/US2023/063446 WO2023168242A1 (en) 2022-03-01 2023-03-01 Engineered nucleases, compositions, and methods of use thereof

Publications (2)

Publication Number Publication Date
CN119137268A CN119137268A (zh) 2024-12-13
CN119137268B true CN119137268B (zh) 2026-07-17

Family

ID=87884328

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380038039.XA Active CN119137268B (zh) 2022-03-01 2023-03-01 工程化核酸酶、组合物及其使用方法

Country Status (8)

Country Link
US (2) US12054756B2 (cg-RX-API-DMAC10.html)
EP (1) EP4486882A4 (cg-RX-API-DMAC10.html)
JP (1) JP2025507822A (cg-RX-API-DMAC10.html)
KR (1) KR20240152394A (cg-RX-API-DMAC10.html)
CN (1) CN119137268B (cg-RX-API-DMAC10.html)
AU (1) AU2023229364A1 (cg-RX-API-DMAC10.html)
CA (1) CA3253017A1 (cg-RX-API-DMAC10.html)
WO (1) WO2023168242A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230076820A (ko) 2020-09-01 2023-05-31 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 진핵생물 유전체 공학을 위한 합성 미니어처 crispr-cas(casmini) 시스템
JP2025507822A (ja) 2022-03-01 2025-03-21 エピクリスパー バイオテクノロジーズ, インコーポレイテッド 組換えヌクレアーゼならびにその組成物および使用方法
WO2025231397A1 (en) * 2024-05-03 2025-11-06 Tenaya Therapeutics, Inc. Modified hek cell lines for improved aav production
CN118315068B (zh) * 2024-05-15 2025-08-08 西湖实验室(生命科学和生物医学浙江省实验室) 基于蛋白标志物预测卵巢癌患者化疗敏感性的装置、蛋白标志物分类器的构建方法和应用
WO2025264819A1 (en) * 2024-06-18 2025-12-26 Nchroma Bio, Inc. Compositions and methods for epigenetic regulation of znf410 expression

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111886336A (zh) * 2017-11-01 2020-11-03 加利福尼亚大学董事会 Casz组合物和使用方法
CN113811607A (zh) * 2019-03-07 2021-12-17 加利福尼亚大学董事会 CRISPR-Cas效应子多肽和其使用方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2931898E (pt) 2012-12-12 2016-06-16 Harvard College Manipulação e otimização de sistemas, métodos e composições para manipulação de sequências com domínios funcionais
WO2015089473A1 (en) 2013-12-12 2015-06-18 The Broad Institute Inc. Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation
US10648020B2 (en) 2015-06-18 2020-05-12 The Broad Institute, Inc. CRISPR enzymes and systems
AU2016279062A1 (en) 2015-06-18 2019-03-28 Omar O. Abudayyeh Novel CRISPR enzymes and systems
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
US11352647B2 (en) 2016-08-17 2022-06-07 The Broad Institute, Inc. Crispr enzymes and systems
WO2019089808A1 (en) * 2017-11-01 2019-05-09 The Regents Of The University Of California Class 2 crispr/cas compositions and methods of use
US11667917B2 (en) 2017-11-21 2023-06-06 Genkore Co. Ltd. Composition for genome editing using CRISPR/CPF1 system and use thereof
EP3875469A4 (en) 2018-10-29 2022-08-17 China Agricultural University NOVEL CRISPR/CAS12F ENZYME AND SYSTEM
US12258594B2 (en) 2018-12-05 2025-03-25 The Broad Institute, Inc. Cas proteins with reduced immunogenicity and methods of screening thereof
CN113166744B (zh) 2018-12-14 2025-02-07 先锋国际良种公司 用于基因组编辑的新颖crispr-cas系统
WO2020223634A1 (en) 2019-05-01 2020-11-05 Mammoth Biosciences, Inc. Programmable nucleases and methods of use
EP3772329A1 (fr) * 2019-08-08 2021-02-10 PKvitality Systeme de surveillance corporelle comprenant une microaiguille
IL292571A (en) * 2019-10-28 2022-06-01 Targetgene Biotechnologies Ltd Pam-reduced and pam-abolished cas derivatives compositions and uses thereof in genetic modulation
CN114846146B (zh) 2019-10-29 2024-04-12 基恩科雷有限责任公司 用于增加CRISPR/Cas12f1系统的效率的工程化引导RNA及其用途
KR20230076820A (ko) 2020-09-01 2023-05-31 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 진핵생물 유전체 공학을 위한 합성 미니어처 crispr-cas(casmini) 시스템
CN116568803A (zh) 2020-10-08 2023-08-08 基恩科雷有限责任公司 用于增加CRISPR/Cas12f1系统的效率的包含富含U的尾部的经工程化的引导RNA及其用途
JP2023544817A (ja) 2020-10-08 2023-10-25 ゲンコレ インコーポレイテッド CRISPR/Cas12f1システム効率化のためのエンジニアリングされたガイドRNAおよびその用途
WO2022075816A1 (ko) 2020-10-08 2022-04-14 주식회사 진코어 Crispr/cas12f1(cas14a1) 시스템 효율화를 위한 엔지니어링 된 가이드 rna 및 이의 용도
EP4267252A4 (en) 2020-12-23 2025-07-23 Mammoth Biosciences Inc COMPOSITIONS AND METHODS OF USING PROGRAMMABLE NUCLEASES TO INDUCE CELL DEATH
US20240060088A1 (en) 2021-01-05 2024-02-22 Horizon Discovery Limited Guide RNA Designs and Complexes for Type V Cas Systems
JP2024523394A (ja) 2021-06-17 2024-06-28 エピクリスパー バイオテクノロジーズ, インコーポレイテッド 異常な遺伝子発現を調節するためのシステムおよび方法
KR20230007218A (ko) * 2021-07-05 2023-01-12 주식회사 진코어 초소형 염기교정 시스템 및 이의 용도
JP2024526895A (ja) 2021-07-20 2024-07-19 エピクリスパー バイオテクノロジーズ, インコーポレイテッド 標的遺伝子を調節するための系および方法
AU2022318664A1 (en) 2021-07-30 2024-02-29 Tune Therapeutics, Inc. Compositions and methods for modulating expression of methyl-cpg binding protein 2 (mecp2)
JP2025507822A (ja) 2022-03-01 2025-03-21 エピクリスパー バイオテクノロジーズ, インコーポレイテッド 組換えヌクレアーゼならびにその組成物および使用方法
WO2023172995A1 (en) 2022-03-11 2023-09-14 Epicrispr Biotechnologies, Inc. Systems and methods for genetic modulation to treat ocular diseases
WO2023173120A1 (en) 2022-03-11 2023-09-14 Epicrispr Biotechnologies, Inc. Systems and methods for genetic modulation to treat ocular diseases
EP4490294A4 (en) 2022-03-11 2026-03-18 Epicrispr Biotechnologies Inc GENETIC MODULATION SYSTEMS AND METHODS FOR TREATING LIVER DISEASE
WO2023173110A1 (en) 2022-03-11 2023-09-14 Epicrispr Biotechnologies, Inc. Compositions, systems, and methods for treating familial hypercholesterolemia by targeting pcsk9
JP2025510781A (ja) 2022-03-24 2025-04-15 エピクリスパー バイオテクノロジーズ, インコーポレイテッド 組換え遺伝子エフェクターならびにその組成物および使用方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111886336A (zh) * 2017-11-01 2020-11-03 加利福尼亚大学董事会 Casz组合物和使用方法
CN113811607A (zh) * 2019-03-07 2021-12-17 加利福尼亚大学董事会 CRISPR-Cas效应子多肽和其使用方法

Also Published As

Publication number Publication date
KR20240152394A (ko) 2024-10-21
CN119137268A (zh) 2024-12-13
US20250011742A1 (en) 2025-01-09
US20240035009A1 (en) 2024-02-01
EP4486882A4 (en) 2025-09-17
AU2023229364A1 (en) 2024-09-19
US12054756B2 (en) 2024-08-06
EP4486882A1 (en) 2025-01-08
CA3253017A1 (en) 2023-09-07
WO2023168242A1 (en) 2023-09-07
JP2025507822A (ja) 2025-03-21

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant